OTC醫藥品產業：全球的產業指南

OTC醫藥品產業：全球的產業指南 是由出版商MarketLine在2010年11月所出版的。 這份英文市場調查報告書包含Pages: 283 價格從美金1495起跳。

目錄

Abstract

Datamonitor' s OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry' s prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights
The global OTC pharmaceuticals market grew by 3.9% in 2009 to reach a value of $110.7 billion.

In 2014, the global OTC pharmaceuticals market is forecast to have a value of $131.6 billion, an increase of 18.9% since 2009.

Cough and cold preparations is the largest segment of the global OTC pharmaceuticals market, accounting for 17.6% of the market' s total value.

Europe accounts for 38% of the global OTC pharmaceuticals market value.

Johnson & Johnson is the leading player in the global OTC pharmaceuticals market, generating a 12.8% share of the market' s value.

The global over-the-counter (OTC) pharmaceutical market is highly fragmented, with the top three players holding 23% of the total market b

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

Table of Contents

TABLE OF CONTENTS
EXECUTIVE SUMMARY
INTRODUCTION
What Is This Report About?
Who Is The Target Reader?
Market Definition
GLOBAL OTC PHARMACEUTICALS
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
OTC PHARMACEUTICALS IN ASIAPACIFIC
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
OTC PHARMACEUTICALS IN EUROPE
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
OTC PHARMACEUTICALS IN BELGIUM
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN CANADA
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN CHINA
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN FRANCE
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN GERMANY
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN ITALY
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN JAPAN
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN THE NETHERLANDS
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN SPAIN
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN THE UNITED KINGDOM
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
OTC PHARMACEUTICALS IN THE UNITED STATES
Market Overview
Market Value
Market Segmentation
Market segmentation I
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
Macroeconomic Indicators
COMPANY PROFILES
Johnson & Johnson
GlaxoSmithKline Pl
Bayer A
APPENDIX
Data Research Methodology
About Datamonitor
Disclaimer

LIST OF TABLES
Table 1: Global OTC pharmaceuticals market value: $ million, 2005-09
Table 2: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 3: Global OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 4: Global OTC pharmaceuticals market share: % share, by value, 2009
Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2009
Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 7: Asia-Pacific OTC pharmaceuticals market value: $ million, 2005-09
Table 8: Asia-Pacific OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 9: Asia-Pacific OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 10: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2009
Table 11: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2009
Table 12: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 13: Europe OTC pharmaceuticals market value: $ million, 2005-09
Table 14: Europe OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 15: Europe OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 16: Europe OTC pharmaceuticals market share: % share, by value, 2009
Table 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2009
Table 18: Europe OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 19: Belgium OTC pharmaceuticals market value: $ million, 2005-09
Table 20: Belgium OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 21: Belgium OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 22: Belgium OTC pharmaceuticals market share: % share, by value, 2009
Table 23: Belgium OTC pharmaceuticals market distribution: % share, by value, 2009
Table 24: Belgium OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 25: Belgium size of population (million), 2005-09
Table 26: Belgium gdp (constant 2000 prices, $ billion), 2005-09
Table 27: Belgium gdp (current prices, $ billion), 2005-09
Table 28: Belgium inflation, 2005-09
Table 29: Belgium consumer price index (absolute), 2005-09
Table 30: Belgium exchange rate, 2005-09
Table 31: Canada OTC pharmaceuticals market value: $ million, 2005-09
Table 32: Canada OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 33: Canada OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 34: Canada OTC pharmaceuticals market share: % share, by value, 2009
Table 35: Canada OTC pharmaceuticals market distribution: % share, by value, 2009
Table 36: Canada OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 37: Canada size of population (million), 2005-09
Table 38: Canada gdp (constant 2000 prices, $ billion), 2005-09
Table 39: Canada gdp (current prices, $ billion), 2005-09
Table 40: Canada inflation, 2005-09
Table 41: Canada consumer price index (absolute), 2005-09
Table 42: Canada exchange rate, 2005-09
Table 43: China OTC pharmaceuticals market value: $ million, 2005-09
Table 44: China OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 45: China OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 46: China OTC pharmaceuticals market share: % share, by value, 2009
Table 47: China OTC pharmaceuticals market distribution: % share, by value, 2009
Table 48: China OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 49: China size of population (million), 2005-09
Table 50: China gdp (constant 2000 prices, $ billion), 2005-09
Table 51: China gdp (current prices, $ billion), 2005-09
Table 52: China inflation, 2005-09
Table 53: China consumer price index (absolute), 2005-09
Table 54: China exchange rate, 2005-09
Table 55: France OTC pharmaceuticals market value: $ million, 2005-09
Table 56: France OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 57: France OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 58: France OTC pharmaceuticals market share: % share, by value, 2009
Table 59: France OTC pharmaceuticals market distribution: % share, by value, 2009
Table 60: France OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 61: France size of population (million), 2005-09
Table 62: France gdp (constant 2000 prices, $ billion), 2005-09
Table 63: France gdp (current prices, $ billion), 2005-09
Table 64: France inflation, 2005-09
Table 65: France consumer price index (absolute), 2005-09
Table 66: France exchange rate, 2005-09
Table 67: Germany OTC pharmaceuticals market value: $ million, 2005-09
Table 68: Germany OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 69: Germany OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 70: Germany OTC pharmaceuticals market share: % share, by value, 2009
Table 71: Germany OTC pharmaceuticals market distribution: % share, by value, 2009
Table 72: Germany OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 73: Germany size of population (million), 2005-09
Table 74: Germany gdp (constant 2000 prices, $ billion), 2005-09
Table 75: Germany gdp (current prices, $ billion), 2005-09
Table 76: Germany inflation, 2005-09
Table 77: Germany consumer price index (absolute), 2005-09
Table 78: Germany exchange rate, 2005-09
Table 79: Italy OTC pharmaceuticals market value: $ million, 2005-09
Table 80: Italy OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 81: Italy OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 82: Italy OTC pharmaceuticals market share: % share, by value, 2009
Table 83: Italy OTC pharmaceuticals market distribution: % share, by value, 2009
Table 84: Italy OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 85: Italy size of population (million), 2005-09
Table 86: Italy gdp (constant 2000 prices, $ billion), 2005-09
Table 87: Italy gdp (current prices, $ billion), 2005-09
Table 88: Italy inflation, 2005-09
Table 89: Italy consumer price index (absolute), 2005-09
Table 90: Italy exchange rate, 2005-09
Table 91: Japan OTC pharmaceuticals market value: $ million, 2005-09
Table 92: Japan OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 93: Japan OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 94: Japan OTC pharmaceuticals market share: % share, by value, 2009
Table 95: Japan OTC pharmaceuticals market distribution: % share, by value, 2009
Table 96: Japan OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 97: Japan size of population (million), 2005-09
Table 98: Japan gdp (constant 2000 prices, $ billion), 2005-09
Table 99: Japan gdp (current prices, $ billion), 2005-09
Table 100: Japan inflation, 2005-09
Table 101: Japan consumer price index (absolute), 2005-09
Table 102: Japan exchange rate, 2005-09
Table 103: Netherlands OTC pharmaceuticals market value: $ million, 2005-09
Table 104: Netherlands OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 105: Netherlands OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 106: Netherlands OTC pharmaceuticals market share: % share, by value, 2009
Table 107: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2009
Table 108: Netherlands OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 109: Netherlands size of population (million), 2005-09
Table 110: Netherlands gdp (constant 2000 prices, $ billion), 2005-09
Table 111: Netherlands gdp (current prices, $ billion), 2005-09
Table 112: Netherlands inflation, 2005-09
Table 113: Netherlands consumer price index (absolute), 2005-09
Table 114: Netherlands exchange rate, 2005-09
Table 115: Spain OTC pharmaceuticals market value: $ million, 2005-09
Table 116: Spain OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 117: Spain OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 118: Spain OTC pharmaceuticals market share: % share, by value, 2009
Table 119: Spain OTC pharmaceuticals market distribution: % share, by value, 2009
Table 120: Spain OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 121: Spain size of population (million), 2005-09
Table 122: Spain gdp (constant 2000 prices, $ billion), 2005-09
Table 123: Spain gdp (current prices, $ billion), 2005-09
Table 124: Spain inflation, 2005-09
Table 125: Spain consumer price index (absolute), 2005-09
Table 126: Spain exchange rate, 2005-09
Table 127: United Kingdom OTC pharmaceuticals market value: $ million, 2005-09
Table 128: United Kingdom OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 129: United Kingdom OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 130: United Kingdom OTC pharmaceuticals market share: % share, by value, 2009
Table 131: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2009
Table 132: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 133: United Kingdom size of population (million), 2005-09
Table 134: United Kingdom gdp (constant 2000 prices, $ billion), 2005-09
Table 135: United Kingdom gdp (current prices, $ billion), 2005-09
Table 136: United Kingdom inflation, 2005-09
Table 137: United Kingdom consumer price index (absolute), 2005-09
Table 138: United Kingdom exchange rate, 2005-09
Table 139: United States OTC pharmaceuticals market value: $ million, 2005-09
Table 140: United States OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 141: United States OTC pharmaceuticals Market segmentation II: % share, by value, 2009
Table 142: United States OTC pharmaceuticals market share: % share, by value, 2009
Table 143: United States OTC pharmaceuticals market distribution: % share, by value, 2009
Table 144: United States OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 145: United States size of population (million), 2005-09
Table 146: United States gdp (constant 2000 prices, $ billion), 2005-09
Table 147: United States gdp (current prices, $ billion), 2005-09
Table 148: United States inflation, 2005-09
Table 149: United States consumer price index (absolute), 2005-09
Table 150: United States exchange rate, 2005-09
Table 151: Johnson & Johnson: key facts
Table 152: Johnson & Johnson: key financials ($
Table 153: Johnson & Johnson: key financial ratios
Table 154: GlaxoSmithKline Plc: key facts
Table 155: GlaxoSmithKline Plc: key financials ($
Table 156: GlaxoSmithKline Plc: key financials (£)
Table 157: GlaxoSmithKline Plc: key financial ratios
Table 158: Bayer AG: key facts
Table 159: Bayer AG: key financials ($
Table 160: Bayer AG: key financials (€)
Table 161: Bayer AG: key financial ratios

相關商品

OTC 非處方藥相關市場調查報告書

處方藥改列成藥策略:體重管理與戒煙的新轉換機會，仍存有自我保健的引進促進的課題
Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
價格 : US $ 3500
出版日期 : 2012年04月

全球消費者保健品市場上新產品開發
New Product Developments in Consumer Health
價格 : US $ 2000
出版日期 : 2012年04月

地區概要:亞太地區的消費者保健品趨勢
Regional Overview: Consumer Health Trends in Asia Pacific
價格 : US $ 2000
出版日期 : 2012年03月

MarketLine發行的製藥相關市場調查報告書

醫藥品產業:全球產業年鑑

Pharmaceuticals: Global Industry Almanac

價格 : US $ 2995

出版日期 : 2012年01月

醫藥品產業:全球產業指南

Pharmaceuticals: Global Industry Guide

價格 : US $ 1495

出版日期 : 2012年01月

醫藥品產業:BRIC各國(巴西，俄羅斯，印度，中國)產業旅遊指南

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

價格 : US $ 995

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!